focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
🐈⬛
The biggest failure is CDT
- In a previous RNS vela mentioned the PUT deal was something they thought was amazing for Vela.
But is it now ??
Despite a few shares like CSFS, MWE, etc rising, let’s not ignore the bigger picture with Vela investments.
Namely the failures with -
- Mode (had the chance to sell above 75p but is now at 2p)
- TSP (didn’t bother doing any DD and currently well below par)
The silence says it all.
Goodnight.
Lack of responses to this thread will mean people on here are as clueless as the BoD.
I wonder if Vela or Ciz actually did any DD before going for the PUT option ?
Appears now that was all a mistake. 🤦♂️
Clearly CDT is the issue here.
Not looking good at all!
CDT is a big worry now, wished Vela just sold the lot while in the 3’s.
Things could get very ugly quickly.
Yes, if there is no positive news to counteract the dilution.
Well done Hoggie.
You mean from VELA and GDR hoggie ?
The clinical tests were thought to take place sooner than they will now.
True or false ?
No chance.
It’ll take time for the products to get commercialised!
“The Company’s expectation is to generate operating losses and negative operating cash flows in the future and will need additional funding to support its current business plan. Management’s plans to alleviate the conditions that raise substantial doubt include the pursuit of additional cash resources through public or private equity or debt financings. There is no assurance that such funding will be available when needed or on acceptable terms. If additional funding is not available when required, the Company would need to delay or curtail its operations and its research and development activities until such funding is received, all of which could have a material adverse effect on the Company and its financial condition.”
“The Company’s expectation is to generate operating losses and negative operating cash flows in the future and will need additional funding to support its current business plan. Management’s plans to alleviate the conditions that raise substantial doubt include the pursuit of additional cash resources through public or private equity or debt financings. There is no assurance that such funding will be available when needed or on acceptable terms. If additional funding is not available when required, the Company would need to delay or curtail its operations and its research and development activities until such funding is received, all of which could have a material adverse effect on the Company and its financial condition.”
Genomics will have to take off in a massive way.
9p will be a miracle!
What if the price drops below 1.5p ?
Has the Bod got something to stop this happening as it usually happens during placings ?
Thank god!
Tiger, any market sensitive news needs to be disclosed ASAP, they cannot withhold such info.